Trademark: 90566145
Word
QUALIGEN THERAPEUTICS
Status Date
Monday, November 28, 2022
Filing Date
Monday, March 8, 2021
Published for Opposition
Tuesday, August 31, 2021
Abandoned Date
Monday, November 28, 2022
10 Medical devices for use in treating or diagnosing viral infections; Medical devices for use in treating or diagnosing cancer
The mark consists of A stylized circle having two regions of shading gradients and inside the circle there are a series of dots with some of the dots having a lines originating from the dots or connecting the dots, underneath the stylized circle is the word "qualigen" in a stylized font in lowercase letters, underneath "qualigen" is the word "therapeutics" between the "q" and the "g" of "qualigen" in a stylized font in capital letters and the "i" in "qualigen" has a lighter shaded dot.
Color is not claimed as a feature of the mark.
"THERAPEUTICS"
Nov 28, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 28, 2022
Abandonment - No Use Statement Filed
Jul 21, 2022
Corrected Noa E-Mailed
Jul 20, 2022
Divisional Processing Complete
Jun 22, 2022
Divisional Request Received
Jul 18, 2022
Case Assigned To Intent To Use Paralegal
Jun 22, 2022
Teas Request To Divide Received
Apr 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 25, 2022
Sou Extension 1 Granted
Apr 25, 2022
Sou Extension 1 Filed
Apr 25, 2022
Teas Extension Received
Oct 26, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 31, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 31, 2021
Published For Opposition
Aug 11, 2021
Notification Of Notice Of Publication E-Mailed
Jul 23, 2021
Approved For Pub - Principal Register
Jul 23, 2021
Examiner's Amendment Entered
Jul 23, 2021
Notification Of Examiners Amendment E-Mailed
Jul 23, 2021
Examiners Amendment E-Mailed
Jul 23, 2021
Examiners Amendment -Written
Jul 22, 2021
Assigned To Examiner
Jun 8, 2021
Notice Of Design Search Code E-Mailed
Jun 7, 2021
New Application Office Supplied Data Entered In Tram
Mar 11, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
